» Articles » PMID: 12780871

Treatment-latency and Previous Episodes: Relationships to Pretreatment Morbidity and Response to Maintenance Treatment in Bipolar I and II Disorders

Overview
Journal Bipolar Disord
Specialty Psychiatry
Date 2003 Jun 5
PMID 12780871
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To clarify relationships of treatment delay and pretreatment episode count with pretreatment morbidity and responses to maintenance treatments in bipolar disorders.

Methods: In 450 DSM-IV bipolar I (n = 293) or II (n = 157) patients (280 women, 170 men), we evaluated correlations of latency from illness-onset to starting maintenance treatment and pretreatment episode counts with pretreatment morbidity and treatment response. We considered morbidity measures before and during treatment, and their differences.

Results: Latency averaged 7.8 years, with 9.0 episodes per patient, before various maintenance treatments started. Morbidity (percentage of time-ill, episodes per year, first wellness-interval, or proportion of subjects hospitalized or having no recurrences) during maintenance treatment averaging 4.2 years was unrelated to treatment latency or pretreatment episode count. However, pretreatment morbidity was greater with shorter latency, resulting in larger relative reduction of morbidity after earlier treatment.

Conclusions: Greater treatment latency and pretreatment episode count were not followed by greater morbidity during treatment, although longer delay yielded smaller during-versus-before treatment reduction in morbidity. Predictions that longer treatment delay or more pretreatment episodes lead to poorer responses to various maintenance treatments in bipolar I or II disorder were not supported.

Citing Articles

Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical study.

Anmella G, Corponi F, Li B, Mas A, Garriga M, Sanabra M BJPsych Open. 2024; 10(5):e137.

PMID: 39086306 PMC: 11698176. DOI: 10.1192/bjo.2024.716.


Clinical Risk Constellations for the Development of Bipolar Disorders.

Burkhardt E, Pfennig A, Leopold K Medicina (Kaunas). 2021; 57(8).

PMID: 34440998 PMC: 8399353. DOI: 10.3390/medicina57080792.


Early detection of bipolar disorders and treatment recommendations for help-seeking adolescents and young adults: Findings of the Early Detection and Intervention Center Dresden.

Martini J, Leopold K, Pfeiffer S, Berndt C, Boehme A, Roessner V Int J Bipolar Disord. 2021; 9(1):23.

PMID: 34215910 PMC: 8253866. DOI: 10.1186/s40345-021-00227-3.


Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study.

Kageyama Y, Deguchi Y, Hattori K, Yoshida S, Goto Y, Inoue K Brain Behav. 2021; 11(4):e02075.

PMID: 33599392 PMC: 8035447. DOI: 10.1002/brb3.2075.


Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife).

Pfennig A, Leopold K, Martini J, Boehme A, Lambert M, Stamm T Int J Bipolar Disord. 2020; 8(1):22.

PMID: 32607662 PMC: 7326843. DOI: 10.1186/s40345-020-00183-4.